Clot-busting drug set to save NHS money
Giving a new clot-busting drug to people who have had a stroke could help save the NHS millions of pounds. The National Institute for Health and Care Excellence (NICE) has published its final guidance recommending tenecteplase (also called Metalyse and made by Boehringer Ingelheim) as an option for treating acute ischaemic stroke in adults. The clinical evidence showed tenecteplase was as effective as alteplase, which NICE also recommends, in breaking up blood clots or preventing new blood clots from forming (thrombolytic treatment) after an acute ischaemic stroke.